Volume 6, Issue 5: Trends in Inhaled Antibiotic Therapy
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 6, Issue 5)
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
After participating in this activity, the participant will demonstrate the ability to:
- Describe the clinical use patterns of the available inhaled antibiotics for managing Pseudomonas aeruginosa in patients with cystic fibrosis.
- Summarize the comparative safety and efficacy data between tobramycin nebulizer solution (TNS) and aztreonam for inhalation solution (AZLI).
- Summarize the comparative safety and efficacy data between tobramycin nebulizer solution (TNS) and colistimethate dry powder for inhalation (CDPI).
Daniel Heintz, MD
Fellow, Pediatric Cystic Fibrosis Center
Nationwide Children’s Hospital
- 1.00 ANCC
- 1.00 Attendance